D J Groeneveld1, E M Alkozai1, J Adelmeijer1, R J Porte2, T Lisman1,2. 1. Surgical Research Laboratory, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands. 2. Section of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Abstract
BACKGROUND: Conventional coagulation tests are frequently prolonged after liver surgery, suggesting a postoperative bleeding tendency. At the same time, thrombotic complications following partial hepatectomy (PH) are not uncommon. Little is known about changes in the platelet adhesive protein von Willebrand factor (VWF) and its cleaving protease a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13 (ADAMTS13) following a PH. METHODS: Plasma samples were collected before and after PH and pylorus-preserving pancreaticoduodenectomy (PPPD), and from 24 healthy individuals. Plasma levels of VWF and ADAMTS13, VWF activity and VWF-dependent platelet adhesion were measured, and compared between the groups. RESULTS: Median (i.q.r.) VWF levels increased more after PH (17 patients) than following PPPD (10), reaching the highest level on postoperative day (POD) 3 (570 (473-656) versus 354 (305-476) per cent respectively; P = 0·009). VWF levels remained raised on POD 30. A decrease in median (i.q.r.) ADAMTS13 activity was observed for both patient groups, reaching the lowest level on POD 7 (24 (16-32) versus 38 (23-66) per cent for PH and PPPD respectively; P = 0·049), and levels remained significantly reduced at POD 30. VWF activity was significantly higher on day 7 following PH compared with PPPD (median (i.q.r.) 517 (440-742) versus 385 (322-484) per cent respectively; P = 0·009), and remained increased at POD 30. VWF-dependent platelet adhesion under conditions of flow was increased until POD 30 in patients after PH and PPPD, but was more pronounced in the PH group. CONCLUSION: There are changes in the balance between VWF and ADAMTS13 levels and activity in patients after both PH and PPPD. Changes in the VWF-ADAMTS13 axis were more pronounced and of longer duration after PH than following PPPD.
BACKGROUND: Conventional coagulation tests are frequently prolonged after liver surgery, suggesting a postoperative bleeding tendency. At the same time, thrombotic complications following partial hepatectomy (PH) are not uncommon. Little is known about changes in the platelet adhesive protein von Willebrand factor (VWF) and its cleaving protease a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13 (ADAMTS13) following a PH. METHODS: Plasma samples were collected before and after PH and pylorus-preserving pancreaticoduodenectomy (PPPD), and from 24 healthy individuals. Plasma levels of VWF and ADAMTS13, VWF activity and VWF-dependent platelet adhesion were measured, and compared between the groups. RESULTS: Median (i.q.r.) VWF levels increased more after PH (17 patients) than following PPPD (10), reaching the highest level on postoperative day (POD) 3 (570 (473-656) versus 354 (305-476) per cent respectively; P = 0·009). VWF levels remained raised on POD 30. A decrease in median (i.q.r.) ADAMTS13 activity was observed for both patient groups, reaching the lowest level on POD 7 (24 (16-32) versus 38 (23-66) per cent for PH and PPPD respectively; P = 0·049), and levels remained significantly reduced at POD 30. VWF activity was significantly higher on day 7 following PH compared with PPPD (median (i.q.r.) 517 (440-742) versus 385 (322-484) per cent respectively; P = 0·009), and remained increased at POD 30. VWF-dependent platelet adhesion under conditions of flow was increased until POD 30 in patients after PH and PPPD, but was more pronounced in the PH group. CONCLUSION: There are changes in the balance between VWF and ADAMTS13 levels and activity in patients after both PH and PPPD. Changes in the VWF-ADAMTS13 axis were more pronounced and of longer duration after PH than following PPPD.
Authors: Nikita Joshi; Anna K Kopec; Jessica L Ray; Holly Cline-Fedewa; Dafna J Groeneveld; Ton Lisman; James P Luyendyk Journal: Toxicol Appl Pharmacol Date: 2017-05-17 Impact factor: 4.219
Authors: Dafna Groeneveld; David Pereyra; Zwanida Veldhuis; Jelle Adelmeijer; Petra Ottens; Anna K Kopec; Patrick Starlinger; Ton Lisman; James P Luyendyk Journal: Blood Date: 2019-01-17 Impact factor: 22.113
Authors: Dafna Groeneveld; Holly Cline-Fedewa; Kevin S Baker; Kurt J Williams; Robert A Roth; Karen Mittermeier; Ton Lisman; Joseph S Palumbo; James P Luyendyk Journal: J Hepatol Date: 2019-10-10 Impact factor: 30.083
Authors: Stefanie Haegele; Jennifer Fuxsteiner; David Pereyra; Christoph Koeditz; Benedikt Rumpf; Clara Schuetz; Christian Schwarz; Christine Brostjan; Thomas Gruenberger; Patrick Starlinger Journal: Sci Rep Date: 2018-11-14 Impact factor: 4.379
Authors: Yvonne de Vries; Isabel M A Brüggenwirth; Shanice A Karangwa; Fien A von Meijenfeldt; Otto B van Leeuwen; Laura C Burlage; Iris E M de Jong; Annette S H Gouw; Vincent E de Meijer; Ton Lisman; Robert J Porte Journal: Transplant Direct Date: 2021-08-05
Authors: Ellen G Driever; R Todd Stravitz; Jingwen Zhang; Jelle Adelmeijer; Valerie Durkalski; William M Lee; Ton Lisman Journal: Hepatology Date: 2021-05 Impact factor: 17.425